Loading compare…
4 funds hold both · as on May 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 4 mutual funds hold active equity positions in both Sudeep Pharma and Sun Pharmaceutical Industries. The scheme with the highest combined exposure is SBI Healthcare Opportunities Fund (SBI MF), which holds a 2.21% stake in Sudeep Pharma and a 11.03% stake in Sun Pharmaceutical Industries, amounting to a combined conviction weight of 13.24%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Sudeep wt. | Sun wt. | Combined |
|---|---|---|---|
| SBI Healthcare Opportunities FundSBI MF · Sectoral / Thematic | 2.21% | 11.03% | |
| UTI - Healthcare FundUTI MF · Sectoral / Thematic | 1.72% | 8.87% | |
| ICICI Prudential MNC FundICICI Pru MF · Sectoral / Thematic | 1.09% | 3.78% | |
| HDFC Manufacturing FundHDFC MF · Sectoral / Thematic | 0.63% | 1.87% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on May 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.